Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

[Aneurysmal bone cyst].

PMID: 25617976
Revista: ANALES DE PEDIATRIA
Any: 2015
Referència: An Pediatr (Barc). 2015 Aug;83(2):138-9. doi: 10.1016/j.anpedi.2014.12.001. Epub 2015 Jan 22.
Factor d'impacte: 0.833
Tipus de publicació: Carta o abstract
Autors: de Pablo Marquez, B, Grange Sobe, I P, Piza Oliveras, A, Veloso Duran, M et al.
DOI: 10.1016/j.anpedi.2014.12.001

[Aneurysmal bone cyst].

PMID: 25617976
Revista: AN PEDIATR
Any: 2015
Referència: An Pediatr (Barc). 2015 Aug;83(2):138-9. doi: 10.1016/j.anpedi.2014.12.001. Epub 2015 Jan 22.
Factor d'impacte:
Tipus de publicació: Carta o abstract
Autors: de Pablo Marquez, B; Grange Sobe, I P; Piza Oliveras, A; Veloso Duran, M et al.
DOI: 10.1016/j.anpedi.2014.12.001

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

PMID: 25219463
Revista: INTERNATIONAL JOURNAL OF CANCER
Any: 2015
Referència: Int J Cancer. 2015 Apr 15;136(8):1863-73. doi: 10.1002/ijc.29213. Epub 2014 Sep 29.
Factor d'impacte: 5.085
Tipus de publicació: Article en revista internacional
Autors: Salvesen, Helga, Alonso-Alconada, Lorena, Santacana, Maria, Garcia-Sanz, Pablo, Muinelo-Romay, Laura, Colas, Eva, Mirantes, Cristina, Monge, Marta, Cueva, Juan, Oliva, Esther et al.
DOI: 10.1002/ijc.29213

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

PMID: 25219463
Revista: INT J CANCER
Any: 2015
Referència: Int J Cancer. 2015 Apr 15;136(8):1863-73. doi: 10.1002/ijc.29213. Epub 2014 Sep 29.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Abal, Miguel; Alonso-Alconada, Lorena; Colas, Eva; Cueva, Juan; Dolcet, Xavier; Garcia-Sanz, Pablo; Gil-Moreno, Antonio; Krakstad, Camilla; Lopez, Maria Angeles; Lopez-Lopez, Rafael et al.
DOI: 10.1002/ijc.29213

Answer to the recent article by Blot C et al. "Conservative surgical management of persistent leak after sleeve gastrectomy by Roux-en-Y gastro-jejunostomy to the fistulous orifice".

PMID: 26481068
Revista: Journal of Visceral Surgery
Any: 2015
Referència: J Visc Surg. 2015 Nov;152(5):343-4. doi: 10.1016/j.jviscsurg.2015.09.012. Epub 2015 Oct 21.
Factor d'impacte: 1.75
Tipus de publicació: Carta amb FI
Autors: Vilallonga, R, Mahendra, N et al.
DOI: 10.1016/j.jviscsurg.2015.09.012

Answer to the recent article by Blot C et al. "Conservative surgical management of persistent leak after sleeve gastrectomy by Roux-en-Y gastro-jejunostomy to the fistulous orifice".

PMID: 26481068
Revista: J VISC SURG
Any: 2015
Referència: J Visc Surg. 2015 Nov;152(5):343-4. doi: 10.1016/j.jviscsurg.2015.09.012. Epub 2015 Oct 21.
Factor d'impacte:
Tipus de publicació: Carta amb FI
Autors: Mahendra, N; Vilallonga, R et al.
DOI: 10.1016/j.jviscsurg.2015.09.012

Antenatal corticosteroids and perinatal outcomes in infants born at 23-25 weeks of gestation.

PMID: 25367557
Revista: Journal of Maternal-Fetal & Neonatal Medicine
Any: 2015
Referència: J Matern Fetal Neonatal Med. 2015;28(17):2084-9. doi: 10.3109/14767058.2014.978280. Epub 2014 Nov 25.
Factor d'impacte: 1.208
Tipus de publicació: Article en revista internacional
Autors: Goya, M, Cespedes, M C, Camba, F, Capote, S, Felipe, A, Reixachs, A, Medina, D, Gorraiz, V, Pin, S, Halachian, C et al.
DOI: 10.3109/14767058.2014.978280

Antenatal corticosteroids and perinatal outcomes in infants born at 23-25 weeks of gestation.

PMID: 25367557
Revista: J MATERN-FETAL NEO M
Any: 2015
Referència: J Matern Fetal Neonatal Med. 2015;28(17):2084-9. doi: 10.3109/14767058.2014.978280. Epub 2014 Nov 25.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Cabero, L; Camba, F; Capote, S; Carreras, E; Cespedes, M C; Felipe, A; Gorraiz, V; Goya, M; Gracia, A; Halachian, C et al.
DOI: 10.3109/14767058.2014.978280

Antibiotic prophylaxis in COPD: Why, when, and for whom?

PMID: 24825753
Revista: PULMONARY PHARMACOLOGY & THERAPEUTICS
Any: 2015
Referència: Pulm Pharmacol Ther. 2015 Jun;32:119-23. doi: 10.1016/j.pupt.2014.05.002. Epub 2014 May 11.
Factor d'impacte: 2.57
Tipus de publicació: Article en revista internacional
Autors: Miravitlles, Marc, Anzueto, Antonio et al.
DOI: 10.1016/j.pupt.2014.05.002

Antibiotic prophylaxis in COPD: Why, when, and for whom?

PMID: 24825753
Revista: PULM PHARMACOL THER
Any: 2015
Referència: Pulm Pharmacol Ther. 2015 Jun;32:119-23. doi: 10.1016/j.pupt.2014.05.002. Epub 2014 May 11.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Anzueto, Antonio; Miravitlles, Marc et al.
DOI: 10.1016/j.pupt.2014.05.002

Antibiotic-loaded polypropylene surgical meshes with suitable biological behaviour by plasma functionalization and polymerization.

PMID: 26322724
Revista: BIOMATERIALS
Any: 2015
Referència: Biomaterials. 2015 Dec;71:132-44. doi: 10.1016/j.biomaterials.2015.08.023. Epub 2015 Aug 19.
Factor d'impacte: 8.557
Tipus de publicació: Article en revista internacional
Autors: Cvelbar, U, Quiles, M, Armengol, M, Arbos, M A, Gil, F J, Canal, C, Modic, M, Canal, J M, Labay, C et al.
DOI: 10.1016/j.biomaterials.2015.08.023

Antibiotic-loaded polypropylene surgical meshes with suitable biological behaviour by plasma functionalization and polymerization.

PMID: 26322724
Revista: BIOMATERIALS
Any: 2015
Referència: Biomaterials. 2015 Dec;71:132-44. doi: 10.1016/j.biomaterials.2015.08.023. Epub 2015 Aug 19.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Arbos, M A; Armengol, M; Canal, C; Canal, J M; Cvelbar, U; Gil, F J; Labay, C; Modic, M; Quiles, M et al.
DOI: 10.1016/j.biomaterials.2015.08.023

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.

PMID: 25344373
Revista: Multiple Sclerosis Journal
Any: 2015
Referència: Mult Scler. 2015 Jun;21(7):866-874. doi: 10.1177/1352458514555785. Epub 2014 Oct 24.
Factor d'impacte: 4.822
Tipus de publicació: Article en revista internacional
Autors: Hoftberger, Romana, Sepulveda, Maria, Armangue, Thais, Blanco, Yolanda, Rostasy, Kevin, Calvo, Alvaro Cobo, Olascoaga, Javier, Ramio-Torrenta, Lluis, Reindl, Markus, Benito-Leon, Julian et al.
DOI: 10.1177/1352458514555785

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.

PMID: 25344373
Revista: MULT SCLER J
Any: 2015
Referència: Mult Scler. 2015 Jun;21(7):866-874. doi: 10.1177/1352458514555785. Epub 2014 Oct 24.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Armangue, Thais; Arrambide, Georgina; Benito-Leon, Julian; Blanco, Yolanda; Calvo, Alvaro Cobo; Casanova, Bonaventura; Dalmau, Josep; Graus, Francesc; Hoftberger, Romana; Olascoaga, Javier et al.
DOI: 10.1177/1352458514555785

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs.

PMID: 25543089
Revista: CLINICAL IMMUNOLOGY
Any: 2015
Referència: Clin Immunol. 2015 Mar;157(1):91-101. doi: 10.1016/j.clim.2014.12.005. Epub 2014 Dec 24.
Factor d'impacte: 3.672
Tipus de publicació: Assaig clínic
Autors: Gibbs, Ebrima, Karim, Mohammad Ehsanul, Oger, Joel, Edan, Gilles, Freedman, Mark S, Hartung, Hans Peter, Miller, David, Montalban, Xavier, Pleimes, Dirk, Pohl, Christoph et al.
DOI: 10.1016/j.clim.2014.12.005

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs.

PMID: 25543089
Revista: CLIN IMMUNOL
Any: 2015
Referència: Clin Immunol. 2015 Mar;157(1):91-101. doi: 10.1016/j.clim.2014.12.005. Epub 2014 Dec 24.
Factor d'impacte:
Tipus de publicació: Assaig clínic
Autors: Edan, Gilles; Freedman, Mark S; Gibbs, Ebrima; Hartung, Hans Peter; Karim, Mohammad Ehsanul; Miller, David; Montalban, Xavier; Oger, Joel; Pleimes, Dirk; Pohl, Christoph et al.
DOI: 10.1016/j.clim.2014.12.005

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

PMID: 24816908
Revista: Targeted Oncology
Any: 2015
Referència: Target Oncol. 2015 Mar;10(1):65-76. doi: 10.1007/s11523-014-0315-z. Epub 2014 May 11.
Factor d'impacte: 4
Tipus de publicació: Guia clínica
Autors: Tabernero, Josep, Chawla, Sant P, Kindler, Hedy, Reckamp, Karen, Chiorean, E Gabriela, Azad, Nilofer S, Lockhart, A Craig, Hsu, Cheng-Pang, Baker, Nigel F, Galimi, Francesco et al.
DOI: 10.1007/s11523-014-0315-z

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

PMID: 24816908
Revista: TARGET ONCOL
Any: 2015
Referència: Target Oncol. 2015 Mar;10(1):65-76. doi: 10.1007/s11523-014-0315-z. Epub 2014 May 11.
Factor d'impacte:
Tipus de publicació: Guia clínica
Autors: Azad, Nilofer S; Baker, Nigel F; Baselga, Jose; Beltran, Pedro; Chawla, Sant P; Chiorean, E Gabriela; Galimi, Francesco; Hsu, Cheng-Pang; Kindler, Hedy; Lockhart, A Craig et al.
DOI: 10.1007/s11523-014-0315-z

Antisynthetase antibodies in World Trade Center rescue and recovery workers with inflammatory myositis: comment on the article by Webber et al.

PMID: 26139542
Revista: Arthritis & Rheumatology
Any: 2015
Referència: Arthritis Rheumatol. 2015 Oct;67(10):2791. doi: 10.1002/art.39260.
Factor d'impacte: 0
Tipus de publicació: Carta o abstract
Autors: Pinal-Fernandez, Iago, Selva-O'Callaghan, Albert, Labirua-Iturburu, Ane et al.
DOI: 10.1002/art.39260

Antisynthetase antibodies in World Trade Center rescue and recovery workers with inflammatory myositis: comment on the article by Webber et al.

PMID: 26139542
Revista: Arthritis & rheumatology (Hoboken, N.J.)
Any: 2015
Referència: Arthritis Rheumatol. 2015 Oct;67(10):2791. doi: 10.1002/art.39260.
Factor d'impacte:
Tipus de publicació: Carta o abstract
Autors: Labirua-Iturburu, Ane; Pinal-Fernandez, Iago; Selva-O'Callaghan, Albert et al.
DOI: 10.1002/art.39260

Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.

PMID: 25608583
Revista: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Any: 2015
Referència: J Antimicrob Chemother. 2015 May;70(5):1513-6. doi: 10.1093/jac/dku558. Epub 2015 Jan 20.
Factor d'impacte: 5.313
Tipus de publicació: Article en revista internacional
Autors: Zetterberg, H, Back, David, Podzamczer, Daniel, Vila, Antonia, Niubo, Jordi, Clotet, Bonaventura, Di Yacovo, Maria S, Molto, Jose, Ferrer, Elena, Curran, Adrian et al.
DOI: 10.1093/jac/dku558

Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.

PMID: 25608583
Revista: J ANTIMICROB CHEMOTH
Any: 2015
Referència: J Antimicrob Chemother. 2015 May;70(5):1513-6. doi: 10.1093/jac/dku558. Epub 2015 Jan 20.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Back, David; Clotet, Bonaventura; Curran, Adrian; Di Yacovo, Maria S; Else, Laura; Ferrer, Elena; Gisslen, Magnus; Molto, Jose; Niubo, Jordi; Podzamczer, Daniel et al.
DOI: 10.1093/jac/dku558

Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no.

PMID: 25583834
Revista: Multiple Sclerosis Journal
Any: 2015
Referència: Mult Scler. 2015 Feb;21(2):132-3. doi: 10.1177/1352458514565415. Epub 2015 Jan 12.
Factor d'impacte: 4.822
Tipus de publicació: Article en revista internacional
Autors: Rio, Jordi et al.
DOI: 10.1177/1352458514565415

Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no.

PMID: 25583834
Revista: MULT SCLER J
Any: 2015
Referència: Mult Scler. 2015 Feb;21(2):132-3. doi: 10.1177/1352458514565415. Epub 2015 Jan 12.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Rio, Jordi et al.
DOI: 10.1177/1352458514565415

Publicacions

Cercador de Publicacions

[Aneurysmal bone cyst].

[Aneurysmal bone cyst].

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

Answer to the recent article by Blot C et al. "Conservative surgical management of persistent leak after sleeve gastrectomy by Roux-en-Y gastro-jejunostomy to the fistulous orifice".

Answer to the recent article by Blot C et al. "Conservative surgical management of persistent leak after sleeve gastrectomy by Roux-en-Y gastro-jejunostomy to the fistulous orifice".

Antenatal corticosteroids and perinatal outcomes in infants born at 23-25 weeks of gestation.

Antenatal corticosteroids and perinatal outcomes in infants born at 23-25 weeks of gestation.

Antibiotic prophylaxis in COPD: Why, when, and for whom?

Antibiotic prophylaxis in COPD: Why, when, and for whom?

Antibiotic-loaded polypropylene surgical meshes with suitable biological behaviour by plasma functionalization and polymerization.

Antibiotic-loaded polypropylene surgical meshes with suitable biological behaviour by plasma functionalization and polymerization.

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs.

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs.

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

Antisynthetase antibodies in World Trade Center rescue and recovery workers with inflammatory myositis: comment on the article by Webber et al.

Antisynthetase antibodies in World Trade Center rescue and recovery workers with inflammatory myositis: comment on the article by Webber et al.

Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.

Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.

Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no.

Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no.

Patronat:

Col·labora:

Acreditacions: